Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation

NCT05509933 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Engraftment Syndrome

Interventions

DRUG: Budesonide

Sponsor

Henry Ford Health System